Results 71 to 80 of about 1,597,912 (313)

Blood collection [PDF]

ISBT Science Series, 2008
openaire   +3 more sources

Benefits of monitoring blood glucose by collection of blood on filter paper strips [PDF]

, 2002
Trish Birdsall, Roland Jm, JF Doran, K Palmer   +3 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Frequency of Pre-Analytical Errors and Its Causes in Glucose Specimen Collection: A Cross-Sectional Analysis in Bahawal Victoria Hospital, Pakistan

Pakistan Journal of Medicine and Dentistry
Background: The laboratory testing process comprises the pre-analytical, analytical, and post-analytical phases. The pre-analytical phase has the highest frequency of error among these three stages.
Hafiza Asma Hafiz, Muhammad Umair Naseer, Seemi Tanvir, Raima Kalhoro, Misbah Hafeez, Memona Zia   +5 more
doaj   +1 more source

Simultaneous collection of the portal and superior vena cava blood in conscious rats defined that intestinal epithelium is the major site of glucuronidation, but not sulfation and methylation, of quercetin [PDF]

, 2018
Seiya Tanaka, Manami Oyama, Miyu Nishikawa, Shinichi Ikushiro, Hiroshi Hara   +4 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Biochemically Tracked Variability of Blood Plasma Thawed-State Exposure Times in a Multisite Collection Study

, 2020
Yueming Hu, Claire Mulot, Camille Bourreau, Diane P. Martin, Pierre Laurent‐Puig, Loredana Radoï, Pascal Guénel, Chad R. Borges   +7 more
openalex   +2 more sources

Impact of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Peripheral Blood Progenitor Cell Collections in Canada

, 2023
Matthew D. Seftel, Gaganvir Parmar, Kathy Ganz, Gail Morris, Nicholas Dibdin, Karen Mostert, Tanya Petraszko, Kristjan Paulson, Nora Stevens, Jason T. Weiss, David Allan   +10 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source